Search

everythinglearnresearchcommunity

for

Search:↓

Blocking YAP/TAZ could be a new way to treat skin cancer.

Myoblast transplantation shows promise for treating various muscle and heart conditions.

Lupeol shows promise for hair growth but needs better absorption and safety testing.

Beta-HPV and MCPyV are linked to certain skin cancers, with ongoing research and vaccine development.

Curcuma aeruginosa Roxb. may help treat hair loss by affecting specific biological pathways.

TPA promotes hair growth by increasing stem cell activity and activating specific cell signals.

CTIP2 may help in skin development and maintenance.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Reconstructing temporal points in hair restoration is crucial for a natural look.

Thymic stromal lymphopoietin (TSLP) promotes hair growth by stimulating specific skin cells.

The Cyp11a1 gene variation has a weak link to PCOS, but higher di-hydro-testosterone levels are found in PCOS patients.

The thulium laser and PDRN injections effectively improved hair thickness in patients with pattern hair loss.

The PON1 192R gene variant is linked to a higher risk of psoriasis and heart disease in Western Mexico.

The nutritional supplement Pilopeptan® WOMAN improved hair growth and thickness in women with hair loss.

Using natural polyphenol cross-linkers like tannic acid and green tea extract in perm treatments improves curling and protects hair.

PNKP is essential for keeping adult mouse progenitor cells healthy and growing normally.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Mixed coconut oil/solvent is suitable for cyproterone acetate injections, but more safety checks are needed.

Povidone-iodine nail solution effectively treats nail infections caused by chemotherapy.

Activating TRPV3 stops human hair growth.

The compounded topical solution is safe, stable, and effective for personalized alopecia treatment.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

An 11-year-old girl with compulsive hair pulling was successfully treated with therapy and medication.

A rare scalp tumor was removed from a 49-year-old woman, with a good outlook if benign but needing careful monitoring if malignant.

A standardized scoring system is needed to improve model reliability for predicting hair loss in brain tumor patients treated with proton therapy.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

A new microneedle system effectively delivers a vasodilator to hair follicles, promoting hair growth better than current treatments.

Kevis P.F. may help with hair care when used with other products.

Both penicillamine and tiopronin have significant side effects, but trying the alternative drug can be beneficial if the first is not tolerated.

HOTTIP and miR-10b contribute to glioma therapy resistance by affecting cell behavior, suggesting they could be targets for treatment.